291 related articles for article (PubMed ID: 22675625)
41. Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer.
Piawah S; Venook AP
Cancer; 2019 Dec; 125(23):4139-4147. PubMed ID: 31433498
[TBL] [Abstract][Full Text] [Related]
42. The Role of Targeted Therapy in the Multi-Disciplinary Approach to Colorectal Liver Metastasis.
Ruff SM; Shannon AH; Pawlik TM
Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444625
[TBL] [Abstract][Full Text] [Related]
43. Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer.
Lee SY; Oh SC
Biomed Res Int; 2016; 2016():7590245. PubMed ID: 27127793
[TBL] [Abstract][Full Text] [Related]
44. Locally advanced and metastatic gastric cancer: current management and new treatment developments.
Field K; Michael M; Leong T
Drugs; 2008; 68(3):299-317. PubMed ID: 18257608
[TBL] [Abstract][Full Text] [Related]
45. The potential clinical promise of 'multimodality' metronomic chemotherapy revealed by preclinical studies of metastatic disease.
Kerbel RS; Shaked Y
Cancer Lett; 2017 Aug; 400():293-304. PubMed ID: 28202353
[TBL] [Abstract][Full Text] [Related]
46. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
47. Neoadjuvant immunotherapy for colorectal cancer: Right regimens, right patients, right directions?
Zhu J; Lian J; Xu B; Pang X; Ji S; Zhao Y; Lu H
Front Immunol; 2023; 14():1120684. PubMed ID: 36949951
[TBL] [Abstract][Full Text] [Related]
48. Integration of targeted therapies in gemcitabine chemotherapy regimens.
Blumenschein GR; Herbst RS
Clin Lung Cancer; 2003 Jan; 4(4):217-23. PubMed ID: 14624709
[TBL] [Abstract][Full Text] [Related]
49. Biomarkers for personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
[TBL] [Abstract][Full Text] [Related]
50. Chinese herbal medicines for prevention and treatment of colorectal cancer: From molecular mechanisms to potential clinical applications.
Kong MY; Li LY; Lou YM; Chi HY; Wu JJ
J Integr Med; 2020 Sep; 18(5):369-384. PubMed ID: 32758397
[TBL] [Abstract][Full Text] [Related]
51. New drugs for the treatment of metastatic colorectal cancer.
Cherri S; Libertini M; Zaniboni A
World J Gastrointest Oncol; 2021 Nov; 13(11):1551-1560. PubMed ID: 34853636
[TBL] [Abstract][Full Text] [Related]
52. Second-line systemic therapy for metastatic colorectal cancer.
Mocellin S; Baretta Z; Roqué I Figuls M; Solà I; Martin-Richard M; Hallum S; Bonfill Cosp X
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006875. PubMed ID: 28128439
[TBL] [Abstract][Full Text] [Related]
53. [Chemotherapy in rectal cancer].
Ahn JB
Korean J Gastroenterol; 2006 Apr; 47(4):277-84. PubMed ID: 16632978
[TBL] [Abstract][Full Text] [Related]
54. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies.
Shih T; Lindley C
Clin Ther; 2006 Nov; 28(11):1779-802. PubMed ID: 17212999
[TBL] [Abstract][Full Text] [Related]
55. Basics to advances in nanotherapy of colorectal cancer.
Tiwari A; Saraf S; Jain A; Panda PK; Verma A; Jain SK
Drug Deliv Transl Res; 2020 Apr; 10(2):319-338. PubMed ID: 31701486
[TBL] [Abstract][Full Text] [Related]
56. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
[TBL] [Abstract][Full Text] [Related]
57. Predictive Biomarkers in Colorectal Cancer: From the Single Therapeutic Target to a Plethora of Options.
Rodrigues D; Longatto-Filho A; Martins SF
Biomed Res Int; 2016; 2016():6896024. PubMed ID: 27563673
[TBL] [Abstract][Full Text] [Related]
58. Chemotherapy for colorectal cancer in the elderly.
Kim JH
World J Gastroenterol; 2015 May; 21(17):5158-66. PubMed ID: 25954089
[TBL] [Abstract][Full Text] [Related]
59. Drug development for cancer chemoprevention: focus on molecular targets.
Johnson KA; Brown PH
Semin Oncol; 2010 Aug; 37(4):345-58. PubMed ID: 20816505
[TBL] [Abstract][Full Text] [Related]
60. Current therapies for advanced colorectal cancer.
Aggarwal S; Chu E
Oncology (Williston Park); 2005 Apr; 19(5):589-95. PubMed ID: 15945340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
